🔥 Trending Understanding EBV: The Virus Linked to COVID-19 and Cancer

The Epstein-Barr Virus (EBV) is a common human herpesvirus, and it is notable as the first identified oncogenic (cancer-causing) virus in humans ²⁸. It primarily infects B cells in the human body and can establish a lifelong, dormant infection ⁸¹⁰. While many people are infected with EBV, often without symptoms, it is the primary cause of infectious mononucleosis, commonly known as "mono" ⁴⁷.

How EBV Works and Its Effects

EBV is typically transmitted through saliva, often earning it the nickname "kissing disease" ². Once infected, the virus remains in the body in a latent state, meaning it is inactive but can reactivate under certain conditions ¹⁰. Reactivation can lead to symptoms in the host and make the individual contagious again ¹⁰.

Beyond mononucleosis, EBV has been implicated in various health issues:

• Infectious Mononucleosis: Characterized by fatigue, fever, sore throat, and swollen lymph nodes ⁴.
• Malignancies: EBV is associated with several cancers, including certain lymphomas and nasopharyngeal carcinoma ⁴⁵⁸.
• Other Conditions: It is also thought to play a role in the pathogenesis of chronic fatigue syndrome and hairy leukoplakia of the tongue ⁴.

Diagnosing an active EBV infection can be challenging due to its symptoms mimicking other illnesses, but it can be confirmed through blood tests that detect specific antibodies ⁹.

The Link Between EBV and COVID-19

Recent research, particularly since the emergence of the SARS-CoV-2 virus (which causes COVID-19), has highlighted a significant interaction between EBV and COVID-19. Studies indicate that COVID-19 infection can trigger the reactivation of the dormant EBV in many individuals ³⁷.

Key Observations and Implications:

• EBV Reactivation in COVID-19 Patients: Several studies have observed a high rate of EBV reactivation in patients with acute COVID-19, particularly in those with more severe disease ¹⁷. For instance, a review in 2026 noted that among 104 COVID-19 patients, those in the ICU showed significantly higher median EBV DNA levels compared to those in sub-ICU, alongside an increased B cell count ¹.
• Contribution to Long COVID: The relationship between COVID-19 and EBV reactivation is opening new avenues for understanding and treating Long COVID (also known as post-COVID-19 condition) ³. Many symptoms of Long COVID, such as persistent fatigue, brain fog, and muscle pain, are strikingly similar to those experienced during EBV reactivation or chronic fatigue syndrome ⁶⁷. This has led researchers to suggest that EBV reactivation could be a contributing factor or even a cause of some Long COVID symptoms ³⁶.
• Diagnostic and Treatment Possibilities: The potential link suggests that testing for EBV reactivation in patients newly diagnosed with COVID-19, or those experiencing Long COVID symptoms, might be beneficial ³. This could lead to targeted treatments that address EBV, potentially alleviating some of the prolonged symptoms of Long COVID.
• Dual Threat in Cancer Development: The interaction between EBV and SARS-CoV-2 is also being investigated in the context of cancer development, as both viruses have oncogenic potential ⁵.

In summary, while EBV and COVID-19 are caused by different viruses, the acute stress and immune response triggered by SARS-CoV-2 infection can often reactivate a latent EBV infection. This reactivation is now considered a significant factor in the severity of acute COVID-19 and a potential driver of the debilitating symptoms associated with Long COVID ³⁶.